Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Schuh MP, Bennett MR, Lane A, Jodele S, Laskin BL, Devarajan P.

Pediatr Nephrol. 2019 May;34(5):865-871. doi: 10.1007/s00467-018-4178-x. Epub 2018 Dec 19.

PMID:
30569313
2.

Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study.

Hingorani S, Pao E, Stevenson P, Schoch G, Laskin BL, Gooley T, McDonald GB.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):866-873. doi: 10.2215/CJN.10630917. Epub 2018 Apr 18.

PMID:
29669818
3.

The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply.

Downes KJ, Laskin BL, Fisher BT.

JAMA Pediatr. 2018 May 1;172(5):494-495. doi: 10.1001/jamapediatrics.2018.0038. No abstract available.

PMID:
29507935
4.

Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.

Foster BJ, Mitsnefes MM, Dahhou M, Zhang X, Laskin BL.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):91-99. doi: 10.2215/CJN.04330417. Epub 2017 Dec 14.

5.

Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.

Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE.

JAMA Pediatr. 2017 Dec 4;171(12):e173219. doi: 10.1001/jamapediatrics.2017.3219. Epub 2017 Dec 4.

PMID:
28973124
6.

The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing.

Laskin BL, Jiao J, Baluarte HJ, Amaral S, Furth SL, Akimova T, Hancock WW, Levine MH, Reese PP, Beier UH.

Transplant Direct. 2017 Jul 19;3(8):e199. doi: 10.1097/TXD.0000000000000715. eCollection 2017 Aug.

7.

Quiz Page May 2017: CKD and Nephrotic Syndrome After Allogeneic Hematopoietic Cell Transplantation.

Hogan JJ, Palmer MD, Loren AW, Laskin BL.

Am J Kidney Dis. 2017 May;69(5):A10-A13. doi: 10.1053/j.ajkd.2017.01.040. No abstract available.

PMID:
28434525
8.

Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, Levine MH, Wang Z, Quinn WJ 3rd, Kopinski PK, Wang L, Akimova T, Liu Y, Bhatti TR, Han R, Laskin BL, Baur JA, Blair IA, Wallace DC, Hancock WW, Beier UH.

Cell Metab. 2017 Jun 6;25(6):1282-1293.e7. doi: 10.1016/j.cmet.2016.12.018. Epub 2017 Apr 13.

9.

Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.

Laskin BL, Huang G, King E, Geary DF, Licht C, Metlay JP, Furth SL, Kimball T, Mitsnefes M.

Pediatr Nephrol. 2017 Aug;32(8):1423-1432. doi: 10.1007/s00467-017-3656-x. Epub 2017 Apr 8.

10.

Acute Kidney Injury in Children Admitted With Diabetic Ketoacidosis: Finding the Sweet Spot of Fluid Management.

Laskin BL, Goebel J.

JAMA Pediatr. 2017 May 1;171(5):e170009. doi: 10.1001/jamapediatrics.2017.0009. Epub 2017 May 1. No abstract available.

PMID:
28288241
11.

New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, Laskin BL.

Transfus Apher Sci. 2016 Apr;54(2):181-90. doi: 10.1016/j.transci.2016.04.007. Epub 2016 Apr 25. Review.

12.

The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study.

Laskin BL, Singh HK, Beier UH, Moatz T, Furth SL, Bunin N, Witte D, Goebel J, Davies SM, Dandoy C, Jodele S, Nickeleit V.

Transplantation. 2016 Oct;100(10):e81-7. doi: 10.1097/TP.0000000000001085.

13.

Outcomes Among Children Who Received a Kidney Transplant in the United States From a Hepatitis B Core Antibody-Positive Donor, 1995-2010.

Ruebner RL, Moatz T, Amaral S, Reese PP, Blumberg EA, Smith JM, Danziger-Isakov L, Laskin BL.

J Pediatric Infect Dis Soc. 2016 Dec;5(4):439-445. Epub 2015 Oct 14.

14.

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.

Jodele S, Fukuda T, Mizuno K, Vinks AA, Laskin BL, Goebel J, Dixon BP, Chima RS, Hirsch R, Teusink A, Lazear D, Lane A, Myers KC, Dandoy CE, Davies SM.

Biol Blood Marrow Transplant. 2016 Feb;22(2):307-315. doi: 10.1016/j.bbmt.2015.10.002. Epub 2015 Oct 9.

15.

Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant.

Wallace G, Jodele S, Howell J, Myers KC, Teusink A, Zhao X, Setchell K, Holtzapfel C, Lane A, Taggart C, Laskin BL, Davies SM.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1627-31. doi: 10.1016/j.bbmt.2015.06.009. Epub 2015 Jun 18.

16.

Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant.

Laskin BL, Sullivan KE, Hester J, Goebel J, Davies SM, Jodele S.

Pediatr Blood Cancer. 2015 Sep;62(9):1670-3. doi: 10.1002/pbc.25536. Epub 2015 Apr 1.

17.

Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.

Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.

Clin Nephrol. 2015 Sep;84(3):181-5. doi: 10.5414/CN108532.

18.

Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.

Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D.

Am J Transplant. 2015 May;15(5):1162-72. doi: 10.1111/ajt.13187. Epub 2015 Feb 23.

19.

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP.

Blood Rev. 2015 May;29(3):191-204. doi: 10.1016/j.blre.2014.11.001. Epub 2014 Nov 28. Review.

20.

The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States.

Laskin BL, Mitsnefes MM, Dahhou M, Zhang X, Foster BJ.

Kidney Int. 2015 Mar;87(3):575-83. doi: 10.1038/ki.2014.342. Epub 2014 Oct 15.

21.

Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation.

Laskin BL, Nehus E, Goebel J, Furth S, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2014 Dec;20(12):2056-61. doi: 10.1016/j.bbmt.2014.07.008. Epub 2014 Jul 17.

22.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL.

Blood. 2014 Jul 24;124(4):645-53. doi: 10.1182/blood-2014-03-564997. Epub 2014 May 29.

23.

Extracorporeal therapy for the smallest children.

Laskin BL, Foster BJ.

Lancet. 2014 May 24;383(9931):1785-6. doi: 10.1016/S0140-6736(14)60650-4. No abstract available.

PMID:
24856013
24.

Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, Dixon BP, Teusink A, Pluthero FG, Lu L, Licht C, Davies SM.

Biol Blood Marrow Transplant. 2014 Apr;20(4):518-25. doi: 10.1016/j.bbmt.2013.12.565. Epub 2013 Dec 25.

25.

Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation.

Oshrine B, Bunin N, Li Y, Furth S, Laskin BL.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1702-7. doi: 10.1016/j.bbmt.2013.09.007. Epub 2013 Sep 20.

26.

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, Davies SM, Pluthero FG, Lu L, Laskin BL.

Blood. 2013 Sep 19;122(12):2003-7. doi: 10.1182/blood-2013-05-501445. Epub 2013 Jun 27.

27.

Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC, Davies SM, Jodele S.

Transplantation. 2013 Jul 27;96(2):217-23. doi: 10.1097/TP.0b013e31829807aa.

28.

BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation.

Laskin BL, Denburg M, Furth S, Diorio D, Goebel J, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1175-82. doi: 10.1016/j.bbmt.2013.05.002. Epub 2013 May 9.

29.

Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010.

Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ.

JAMA. 2013 May 8;309(18):1921-9. doi: 10.1001/jama.2013.4208.

30.

High-dose continuous renal replacement therapy for neonatal hyperammonemia.

Spinale JM, Laskin BL, Sondheimer N, Swartz SJ, Goldstein SL.

Pediatr Nephrol. 2013 Jun;28(6):983-6. doi: 10.1007/s00467-013-2441-8. Epub 2013 Mar 8.

31.

Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury.

Nehus EJ, Laskin BL, Kathman TI, Bissler JJ.

Pediatr Nephrol. 2013 Mar;28(3):453-61. doi: 10.1007/s00467-012-2341-3. Epub 2012 Nov 10.

PMID:
23142864
32.

Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?

Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM, Davies SM.

Transfusion. 2013 Mar;53(3):661-7. doi: 10.1111/j.1537-2995.2012.03776.x. Epub 2012 Jul 15.

33.

Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.

Laskin BL, Goebel J, Starke JR, Schauer DP, Eckman MH.

Am J Kidney Dis. 2013 Jan;61(1):22-32. doi: 10.1053/j.ajkd.2012.06.004. Epub 2012 Jul 10.

34.

Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation.

Laskin BL, Nehus E, Goebel J, Khoury JC, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2012 Nov;18(11):1745-52. doi: 10.1016/j.bbmt.2012.06.006. Epub 2012 Jun 16.

35.

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Laskin BL, Goebel J, Davies SM, Jodele S.

Blood. 2011 Aug 11;118(6):1452-62. doi: 10.1182/blood-2011-02-321315. Epub 2011 May 19. Review.

36.

Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation.

Haines HL, Laskin BL, Goebel J, Davies SM, Yin HJ, Lawrence J, Mehta PA, Bleesing JJ, Filipovich AH, Marsh RA, Jodele S.

Biol Blood Marrow Transplant. 2011 Oct;17(10):1512-9. doi: 10.1016/j.bbmt.2011.02.012. Epub 2011 Mar 6.

37.

BK virus nephropathy in a pediatric autologous stem-cell transplant recipient.

Sanchez-Pinto LN, Laskin BL, Jodele S, Hummel TR, Yin HJ, Goebel J.

Pediatr Blood Cancer. 2011 Mar;56(3):495-7. doi: 10.1002/pbc.22860. Epub 2010 Nov 11.

PMID:
21225938
38.

Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.

Jodele S, Bleesing JJ, Mehta PA, Filipovich AH, Laskin BL, Goebel J, Pinkard SL, Davies SM.

Pediatr Transplant. 2012 Mar;16(2):E39-42. doi: 10.1111/j.1399-3046.2010.01408.x. Epub 2010 Nov 5.

PMID:
21054715
39.

Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.

Laskin BL, Goebel J, Davies SM, Khoury JC, Bleesing JJ, Mehta PA, Filipovich AH, Paff ZN, Lawrence JM, Yin HJ, Pinkard SL, Jodele S.

Bone Marrow Transplant. 2011 May;46(5):682-9. doi: 10.1038/bmt.2010.182. Epub 2010 Aug 9.

PMID:
20697372
40.

Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature.

Laskin BL, Goebel J.

Pediatr Transplant. 2010 Aug;14(5):589-95. doi: 10.1111/j.1399-3046.2010.01318.x. Epub 2010 Mar 28. Review.

PMID:
20353405
41.

A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL).

Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL.

Eur J Cancer Care (Engl). 2005 Mar;14(1):53-62. Review.

PMID:
15698386
42.

The clinical and epidemiological burden of chronic lymphocytic leukaemia.

Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL.

Eur J Cancer Care (Engl). 2004 Jul;13(3):279-87. Review.

PMID:
15196232
43.

Quality of life aspects of bladder cancer: a review of the literature.

Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A.

Qual Life Res. 2003 Sep;12(6):675-88. Review.

PMID:
14516177
44.

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.

Redaelli A, Stephens JM, Laskin BL, Pashos CL, Botteman MF.

Expert Rev Anticancer Ther. 2003 Jun;3(3):311-29. Review.

PMID:
12820775
45.

Bladder cancer: epidemiology, diagnosis, and management.

Pashos CL, Botteman MF, Laskin BL, Redaelli A.

Cancer Pract. 2002 Nov-Dec;10(6):311-22. Review.

PMID:
12406054
46.

Novel gastrointestinal tract manifestations in juvenile dermatomyositis.

Laskin BL, Choyke P, Keenan GF, Miller FW, Rider LG.

J Pediatr. 1999 Sep;135(3):371-4.

PMID:
10484806

Supplemental Content

Loading ...
Support Center